The FORWARD STUDY The FORWARD STUDY is an open-label study in North America and Europe. The study has been reviewed and approved for ethics and safety. All patients will receive Tanruprubart. The purpose of this study is to better understand Tanruprubart’s effects by collecting information such as: What is Tanruprubart? Tanruprubart (ANX005) is an investigational…
International Guillain-Barré Syndrome Outcome Study (IGOS) The international GBS Outcome Study (IGOS) is the largest and longest prospective trial designed to collect extensive data from patients afflicted with GBS in a systematic manner. The aim is to collect information from patients by intensive international collaboration. All patients are followed at standard intervals from the earliest…
Spotlight
